The time is now for pharma to take next steps in tech adoption.
Lance Scott
Advertisement
Articles by Lance Scott
Advertisement
Latest Updated Articles
Data Inflection PointPublished: September 5th 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
2
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
3
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
4
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
5